In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives

Toxoplasma gondii, an obligate intracellular parasite, is the aetiological agent of toxoplasmosis, a disease that affects approximately 25% – 30% of the world’s population. At present, no safe and effective vaccine exists for the prevention of toxoplasmosis. Current treatment options for toxoplasmos...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huanping, Gao, Yang, N’Da, David D., Xuan, Xuenan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252180/
https://www.ncbi.nlm.nih.gov/pubmed/34212734
http://dx.doi.org/10.4102/ojvr.v88i1.1898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252180/
https://www.ncbi.nlm.nih.gov/pubmed/34212734
http://dx.doi.org/10.4102/ojvr.v88i1.1898

Ejemplares similares